. Research designed to address basic science questions is a vital part of the drug discov DISAGREE DON'T KNOW 6 ery process. AGREE Explain why.
7. Prior to releasing an antiviral drug as a treatment for disease, the drug is first tested in one animal model (for example in a mouse model or in a rabbit model), if no complications are observed, the drug is then tested in humans (clinical trials) AGREE DISAGREE DON'T KNOW Explain why. f. Able to distinguish a peer reviewed article from one that is not peer reviewed g. Able to distinguish an article that is considered a "primary source" from an article that is considered a "secondary source"
I learn best by: (choose one) 1. Listening to a lecture 
Antiviral Drug Research Proposal (50pts)
Basic research and clinical research are both very important in leading to scientific advances The development of antiviral drugs provides an example of how these two different kinds of research must be used together in order to achieve the final goal of treating disease.
You will work in teams of 6 to develop an antiviral drug research proposal. Each team will be assigned a virus and each member of the team will be assigned a specialty. The presurveys, post-surveys, quiz, specialty research report, specialty research report revisions, and presentation of the poster will be handed in individually while the poster will graded as a team effort. Make sure that all members of the team contribute equally because your team members will be grading your participation at the end.
Pre-survey
• Take the HPI concept inventory (1pt) on Course Management System (CMS)
• Take the pre-survey (1pt) during Discussion 1
Project setup/introduction
• You will be assigned to a team of 6 people to work on the antiviral drug for a given virus • You will be assigned a specialty within the team (1-6)
Specialty Research (Post in Specialty Research assignment page in CMS)
• Answer only the questions of your specialty in one page (3pts)
• Utilizing primary literature, answer the questions pertaining to your specialty in the context of your assigned virus.
• Your specialty research can be written as an outline, bullet points, or paragraph form, but must include citations.
• If information is not available for your particular virus, the topics should be researched more generally about the family in which the virus belongs.
• You will work individually to investigate information on your specialty in the context of your assigned virus.
• Your research will be reviewed in the Specialty Research discussion, when you will share your work with the class.
• 
Proposal Preparation and Poster Design (27pts) (post in Proposal assignment page the CMS)
• Work with your Virus team to design a poster to present your antiviral drug research proposal to the organization you will request funding from.
• The poster should be designed in Microsoft PowerPoint™ and posted on CMS before the poster session.
• The presentation should be printed so that it can be attached to a provided tack board.
• An example poster can be found on CMS to give you a place to start with the format and content. Your poster should have more creativity and information than the example.
• Write 3 questions you think other students should be able to answer after visiting your poster.
Poster session (10 pts)
• Each team will be given a number and will set up their poster at their numbered spot.
• Each Virus team will be divided into three teams of two and the class time was apportioned into three twelve-minute sessions.
• While one team of two is presenting their poster, the other four members will visit the posters of other teams.
• At the end of each twelve minutes session, the two presenters will visit other posters and a new team of two will present.
• Instructors will visit all posters to assess presentation of the material by all members of each team.
Postsurvey and quiz
• Take 3 of the 10 quizzes designed by other teams (4.5pts)
• Take graphical data comprehension quiz (0.5pt)
• Take Specialty research report revisions (1pt) 1pt -Posted assignment differs from specialty research report in that it contains additional correct information revealing that they have reconciled and sibility and evaluated research models considering ethics, efficacy, and fea come to a consensus on the team topic pt ent is the same as the Specialty research report 0 -Posted assignm (see table) 2pts-Contributed to both online and in-class discussion 1pt -contributed either online or in-class discussion 0pt -contributed neither online or in-class discussion Proposal Development (26.5pts) Section 4a (Drug development process) Target (3pts) e cycle, (2)choice of target, 3pts -Student's research model strongly supports (1)lif and (3)reasoning behind drug development is explained incor incorr 2pts -One of the three concepts rectly 1pt -Two of the three concepts is explained ectly 0pts -Student's research model does not support life cycle, choice of target, and reasoning behind drug development Highthroughput screen (3pts) d source correct 3pts -Student's research strongly supports choice of screen and compoun rtially 2.5pts -Explanation of the choice of screen or compound source is pa 2pts -Explanation of the choice of screen or compound source is incorrect 1.5pts -Either choice of screen or compound source is not explained or compound so een or compound 1pt -Only choice of screen urce is explained, but is partially correct .5pts -Only choice of scr source is explained, but is incorrect pts -Student's research does not explain choice of screen and compound source 0 0
Cellbased screen (3pts) 3pts -Student's research strongly supports effectiveness screen and toxicity correct screen lly 2.5pts -Explanation of effectiveness screen or toxicity screen is partia 2pts -Explanation of effectiveness screen or toxicity screen is incorrect ect 1.5pts -Either effectiveness screen or toxicity screen is not explained reen or toxicity s orr screen or toxicit ct 1pt -Only effectiveness sc creen is explained, but is partially c 0.5pts -Only effectiveness y screen is explained, but is incorre pts -Student's research does not explain choice of effectiveness screen and toxicity screen 0 Animal models (3pts) 3pts -Student's research strongly supports animal models and steps to clinical correct trials lly 2.5pts -Explanation of animal models or steps to clinical trials is partia 2pts -Explanation of animal models or steps to clinical trials is incorrect 1.5pts -Either animal models or steps to clinical trials is not explained 1pt -Only animal models or steps to clinical trials is explained, but is partially ls or steps to clin correct .5pts -Only animal mode ical trials is explained, but is incorrect pts -Student's research does not explain animal models and steps to clinical trials 0 0
Clinical trials (3pts)
and 3pts -Student's research strongly supports method to employ clinical trials ethical issues to consider 2.5pts -Explanation of method to employ clinical trials and ethical issues to consider is partially correct 2pts -Explanation of method to employ clinical trials and ethical issues to consider is incorrect r is not 1.5pts -Either method to employ clinical trials and ethical issues to conside explained 1pt -Only method to employ clinical trials and ethical issues to consider is explained, but is partially correct ploy clinical tria 0.5pts -Only method to em ls and ethical issues to consider is explained, but is incorrect pts -Student's research does not explain method to employ clinical trials and ethical issues to consider 0
Resistance (3pts)
3pts -Student's research strongly supports drug resistance issues to consider and a target funding agency 2.5pts -Explanation of drug resistance issues to consider or a target funding agency is partially correct is 2pts -Explanation of drug resistance issues to consider or a target funding agency incorrect 1.5pts -Either drug resistance issues to consider or a target funding agency is not explained lained, 1pt -Only drug resistance issues to consider or a target funding agency is exp but is partially correct ce issues to cons 0.5pts -Only drug resistan ider or a target funding agency is explained, but is incorrect 0pts -Student's research does not explain choice of drug resistance issues to consider and a target funding agency 
Post-survey
Dear Students, our goal is to understand your learning in Virology lecture. To do so, we would appreciate your input. Please complete this survey. This is an anonymous survey of students in Virology lecture and although your responses will not affect your grade, completion will be worth 1 point of the antiviral drug research proposal. Thank you! * Required 1. I am aware of the type and scale of scientific research that is occurring in labs at the University of Maryland Explain one fact you learned about antiviral drug development for O'nyong-nyong virus.
Explain one fact you learned about antiviral drug development for Nounane virus.
Explain one fact you learned about antiviral drug development for Desert Shield virus.
Explain one fact you learned about antiviral drug development for Human Papillomavirus 13.
Explain one fact you learned about antiviral drug development for Yaba monkey tumor virus.
Explain one fact you learned about antiviral drug development for Thogotovirus.
Explain one fact you learned about antiviral drug development for Parvovirus B19.
Explain one fact you learned about antiviral drug development for Coltivirus.
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Team assessment
Please type each group member's name then rate their level of participation in the following question.
Your name
What group number are you in?
1a. Name one person in your group. [10] Compound source: compound library from a drug company which will contain thousands of compounds that will be narrowed down In Vitro Screening Cont'…..
RT-PCR
• Cells can be treated with increasing concentration of the antiviral drug • C33-A is HPV negative cell line • RT-PCR assay result shows inhibition of E7 as concentration of the antiviral drug increases. 
Screening for Compounds Toxicity
• Apoptosis determination
• Control (noninfectious) cells are untreated (top).
• Infectious cell are treated with staurosporine to induce apoptosis(bottom).
• Increased Annexin V staining is seen in infectious cells only in the presence of staurosporine.
• PI (propidium iodide)an Annexin are two widely used dyes. 
